Repurposing FDA-Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease.
ChemistryOpen
; 10(9): 877-881, 2021 09.
Article
in En
| MEDLINE
| ID: mdl-33377311
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Aminoacyltransferases
/
Enzyme Inhibitors
/
Small Molecule Libraries
/
Drug Repositioning
Limits:
Humans
Language:
En
Journal:
ChemistryOpen
Year:
2021
Type:
Article
Affiliation country:
China